Compare VATE & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VATE | PETS |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Retail-Drug Stores and Proprietary Stores |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 63.7M |
| IPO Year | 1996 | N/A |
| Metric | VATE | PETS |
|---|---|---|
| Price | $4.54 | $3.71 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.20 |
| AVG Volume (30 Days) | 24.7K | ★ 7.6M |
| Earning Date | 11-12-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,099,900,000.00 | $226,972,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.05 | $1.57 |
| 52 Week High | $13.79 | $5.80 |
| Indicator | VATE | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 38.98 | 74.81 |
| Support Level | $4.16 | $1.69 |
| Resistance Level | $5.28 | $4.10 |
| Average True Range (ATR) | 0.27 | 0.36 |
| MACD | -0.05 | 0.26 |
| Stochastic Oscillator | 33.03 | 83.79 |
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.